| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |